MiR-892a regulated PPP2R2A expression and promoted cell proliferation of human colorectal cancer cells

Biomedicine and Pharmacotherapy

Volumn 72, Issue , 2015, Pages 119-124

  Liang, Wen long ^a   Cao, Jie ^a   Xu, Bo ^a   Yang, Ping ^a   Shen, Fei ^a   Sun, Zheng ^a   Li, Wang lin ^a   Wang, Qiang ^a   Liu, Feng ^a  

^a GUANGZHOU MEDICAL UNIVERSITY   (China)

Author keywords

Cell proliferation; Colorectal cancer; MiR 892a; PPP2R2A

Indexed keywords

CYCLIN D1; MICRORNA; MICRORNA 892A; PHOSPHOPROTEIN PHOSPHATASE 2A; PROTEIN P21; SERINE THREONINE PROTEIN PHOSPHATASE 2A 55 KDA REGULATORY SUBUNIT B ALPHA ISOFORM; SMALL INTERFERING RNA; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG; 3' UNTRANSLATED REGION; MIRN892 MICRORNA, HUMAN; PHOSPHOPROTEIN PHOSPHATASE 2; PPP2R2A PROTEIN, HUMAN; PROTEIN BINDING;

3' UNTRANSLATED REGION; ANCHORAGE INDEPENDENT GROWTH; ARTICLE; BINDING SITE; CELL PROLIFERATION; CELL VIABILITY; COLONY FORMATION; COLORECTAL CANCER; COLORECTAL CANCER CELL LINE; CONTROLLED STUDY; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN TISSUE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TARGETING; TUMOR SUPPRESSOR GENE; COLORECTAL TUMOR; DOWN REGULATION; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; PATHOLOGY; TUMOR CELL LINE; UPREGULATION;

3' UNTRANSLATED REGIONS; BASE SEQUENCE; CELL LINE, TUMOR; CELL PROLIFERATION; COLORECTAL NEOPLASMS; DOWN-REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICRORNAS; MOLECULAR SEQUENCE DATA; PROTEIN BINDING; PROTEIN PHOSPHATASE 2; UP-REGULATION;

EID: 84930512689     PISSN: 07533322     EISSN: 19506007     Source Type: Journal    
DOI: 10.1016/j.biopha.2015.04.015     Document Type: Article

References (22)

1. Jemal A., Bray F., Center M.M., Ferlay J., Ward E., Forman D. Global cancer statistics. CA Cancer J. Clin. 2011, 61:69-90.
2. Yun J.A., Kim H.C., Park J.S., Cho Y.B., Yun S.H., Lee W.Y. Perioperative and oncologic outcomes of single-incision laparoscopy compared with conventional laparoscopy for colon cancer: an observational propensity score-matched study. Am. Surg. 2015, 81:316-323.
3. Buiting H.M., Terpstra W., Dalhuisen F., Gunnink-Boonstra N., Sonke G.S., den Hartogh G. The facilitating role of chemotherapy in the palliative phase of cancer: qualitative interviews with advanced cancer patients. PloS One 2013, 8:e77959.
4. Cecchin E., Perrone G., Nobili S., Polesel J., De Mattia E., Zanusso C., et al. Mthfr-1298 a>c (rs1801131) is a predictor of survival in two cohorts of stage ii/iii colorectal cancer patients treated with adjuvant fluoropyrimidine chemotherapy with or without oxaliplatin. Pharmacogenomics J. 2014, (Epub ahead of print). 10.1038/tpj.2014.64.
5. Kim M., Son S.H., Won Y.K., Kay C.S. Stereotactic ablative radiotherapy for oligometastatic disease in liver. Bio. Med. Res. Int. 2014, 2014:340478.
6. Bartel D.P. Micrornas: genomics, biogenesis, mechanism, and function. Cell 2004, 116:281-297.
7. Ambros V. The functions of animal micrornas. Nature 2004, 431:350-355.
8. Chen P., Wang B.L., Pan B.S., Guo W. Mir-1297 regulates the growth, migration and invasion of colorectal cancer cells by targeting cyclo-oxygenase-2. Asian Pac. J. Cancer Prev. 2014, 15:9185-9190.
9. Wu L., Li Y., Fan J.M., Zhang Z.M., Ouyang J.L., Ni T.T., et al. Microrna-204 targets signal transducer and activator of transcription 5 expression and inhibits proliferation of b-cell lymphoma cells. Mol. Med. Rep. 2015, 11:4567-4572.
10. Zhang H.D., Jiang L.H., Sun D.W., Li J., Tang J.H. Mir-139-5p: Promising biomarker for cancer. Tumour Biol. 2015, 36:1355-1365.
11. Feng T., Xu D., Tu C., Li W., Ning Y., Ding J., et al. Mir-124 inhibits cell proliferation in breast cancer through downregulation of cdk4. Tumour Biol. 2015, (Epub ahead of print).
12. Li W.B., Chen H.Y., Zhang W., Yan W., Shi R., Li S.W., et al. Relationship between magnetic resonance imaging features and mirna gene expression in patients with glioblastoma multiforme. Chin. Med. J. (Engl) 2013, 126:2881-2885.
13. Kuo Y.C., Huang K.Y., Yang C.H., Yang Y.S., Lee W.Y., Chiang C.W. Regulation of phosphorylation of thr-308 of akt, cell proliferation, and survival by the b55alpha regulatory subunit targeting of the protein phosphatase 2a holoenzyme to akt. J. Biol. Chem. 2008, 283:1882-1892.
14. Wang X., Lin C., Zhao X., Liu A., Zhu J., Li X., et al. Acylglycerol kinase promotes cell proliferation and tumorigenicity in breast cancer via suppression of the foxo1 transcription factor. Mol. Cancer 2014, 13:106.
15. Xie G., Li J., Chen J., Tang X., Wu S., Liao C. Knockdown of flotillin-2 impairs the proliferation of breast cancer cells through modulation of akt/foxo signaling. Oncol. Rep. 2015, 33:2285-2290.
16. Rajendiran S., Parwani A.V., Hare R.J., Dasgupta S., Roby R.K., Vishwanatha J.K. Microrna-940 suppresses prostate cancer migration and invasion by regulating mien1. Mol. Cancer 2014, 13:250.
17. Shen F., Cai W.S., Feng Z., Li J.L., Chen J.W., Cao J., et al. Mir-492 contributes to cell proliferation and cell cycle of human breast cancer cells by suppressing sox7 expression. Tumour Biol. 2015, 36:1913-1921.
18. Zhang J., Zhou Y., Ma L., Huang S., Wang R., Gao R., et al. The alteration of mir-222 and its target genes in nickel-induced tumor. Biol. Trace Elem. Res. 2013, 152:267-274.
19. Ruvolo P.P., Ruvolo V.R., Jacamo R., Burks J.K., Zeng Z., Duvvuri S.R., et al. The protein phosphatase 2a regulatory subunit b55alpha is a modulator of signaling and microrna expression in acute myeloid leukemia cells. Biochim. Biophys. Acta 2014, 1843:1969-1977.
20. Shen S., Yue H., Li Y., Qin J., Li K., Liu Y., et al. Upregulation of mir-136 in human non-small cell lung cancer cells promotes erk1/2 activation by targeting ppp2r2a. Tumour Biol. 2014, 35:631-640.
21. Cristobal I., Manso R., Rincon R., Carames C., Senin C., Borrero A., et al. Pp2a inhibition is a common event in colorectal cancer and its restoration using fty720 shows promising therapeutic potential. Mol. Cancer Ther. 2014, 13:938-947.
22. Cheng Y., Liu W., Kim S.T., Sun J., Lu L., Sun J., et al. Evaluation of ppp2r2a as a prostate cancer susceptibility gene: a comprehensive germline and somatic study. Cancer Genet. 2011, 204:375-381.